Insight

Sakditad Saowapa: Great Talks Ensure the Audience Leaves Knowing Something They Didn’t Before

Sakditad Saowapa/X

Aug 29, 2025, 15:19

Sakditad Saowapa: Great Talks Ensure the Audience Leaves Knowing Something They Didn’t Before

Sakditad Saowapa, Hematology/Oncology Fellow at University of Iowa, shared on LinkedIn:

“An Oncologist’s Guide to Ensuring Your First Medical Grand Rounds Will Be Your Last
By David H. Johnson, (JCO OP, Aug 2025)

Here are 7 surefire ways to make sure you’re never invited back:

Microscopic Mayhem – Start with an endless deep dive into tumor histology + molecular markers. Bonus if 90% of the room has no idea what you’re talking about.
TNM Torture – Review every tiny change in staging systems. Use the smallest font chart possible. Guaranteed seat-shifting boredom.
MOA Overload – Describe every drug’s mechanism of action in detail – especially if irrelevant to your audience. Extra points for slack-jawed stares.
Dosage Deadlock – Spend 10 minutes on dose escalation strategies only oncologists care about. Internists will cry inside.
Criteria Catatonia – Dive deep into RECIST or obscure imaging criteria. Perfect way to turn burritos into projectiles.
Kaplan-Meier Killer – Show 10 hard-to-read survival curves from negative trials. The room will collapse into collective despair.
Lymph Node Lobotomy – Close with exhaustive surgical detail—precise node counts and obscure dissections. Stupor guaranteed.

Lesson: The inverse of these 7 rules = how to deliver a brilliant Grand Rounds.

Know your audience
Stay clinically relevant
Make complexity accessible

Great talks don’t show how much you know – They ensure the audience leaves knowing something they didn’t before.”

Great Talks

More posts featuring Sakditad Saowapa.

cancer Criteria Catatonia David H. Johnson Dosage Deadlock Kaplan-Meier Killer Lymph Node Lobotomy Microscopic Mayhem MOA Overload OncoDaily Oncology Sakditad Saowapa TNM Torture

Why Is Financial Wellness Crucial for Physicians and Health Care Professionals?

BOT/BAL Advancements, BATTMAN Trial, FDA Approval Challenges and Key Highlights from Agenus Stakeholder Briefing

10 Leading Experts Join OncoDaily Journal Editorial Team

Top 10 Oncogrants of the Week: Fueling Cancer Research and Innovation

Soon-Shiong’s “Bioshield” Sparks Early Promise in Recurrent GBM, With 2 Near-CRs and 100% Disease Control